Clinical Trials Directory

Trials / Completed

CompletedNCT05865080

Effect of Intravenous Ketamine Infusion for Hemodynamic Stability in Patients Undergoing Caesarean Delivery.

Effect of Intravenous Ketamine Infusion for Hemodynamic Stability in Patients Undergoing Cesarean Delivery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
126 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
Female
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

Hypotension is the most frequent side effect of intrathecal anesthesia, with a found incidence of more than 80%. With a frequency of between 40% and 60% in patients undergoing surgery, Perioperative shivering is a serious consequence that frequently follows neuraxial anesthesia. This study aimed to determine the multiple advantages of intravenous minimal dose ketamine for intrathecal anesthesia in patients undergoing cesarean delivery

Detailed description

126 female patients undergoing cesarean deliveries, ASA-(II and III) and 21-40 ys old selected from an attendee of outpatient clinics of the Anesthesia Department. Two groups of patients were random to group K (63 patients): Received 0.3 mg/kg of ketamine IV diluted to 10 ml followed by infusion 0.1 mg/kg/hr. as 20 ml solution, group C (Controlled) (63 patients): Received 10 ml of normal saline followed by infusion of 0.1 ml/kg/hr. as 20 ml solution.

Conditions

Interventions

TypeNameDescription
DRUGKetamine0.3 mg/kg of ketamine IV diluted to 10 ml followed by infusion 0.1 mg/kg/hr. as 20 ml solution before spinal anesthesia
DRUGPlaceboNormal saline

Timeline

Start date
2022-07-01
Primary completion
2023-01-01
Completion
2023-02-01
First posted
2023-05-18
Last updated
2023-05-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05865080. Inclusion in this directory is not an endorsement.